Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA
Go back to Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA| (NASDAQ: DARE) | Delayed: 2.08 +0.01 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.07 | 52 Week High | $ | |||
| Open | $2.04 | 52 Week Low | $ | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.00 | EPS | $ | |||
| Volume | 191,534 | |||||

